Deborah Birx Recommends Weekly Testing of Every Cow for Bird Flu

"Since leaving government work, Birx has already earned millions of dollars in the private sector, and has found herself quite a few lucrative opportunities in the Pharma space.

Birx now sits on the advisory board of BGR, one of the most powerful lobbying firms in Washington D.C. Their Pharma client roster includes the likes of Pfizer, Abbott Labs, GSK, and Johnson & Johnson, to name a few.

Birx is also the CEO of a publicly traded company called Armata Pharmaceuticals, through which she was granted about 275,000 shares. As of Wednesday, her holdings in Armata are valued at about $728,750. Birx also earns a base salary of $525,000 per year, and she can earn a massive performance bonus based on the value of the company.

Armata is 70% owned by another publicly traded company called Innoviva, which describes itself as a “Healthcare Royalty and Asset Management” company. Innoviva’s top shareholders include BlackRock and Vanguard, which, through their clients’ positions, control about 25% of Innoviva.

Birx also holds several additional board seats in startup and seasoned Pharma endeavors, some of which may stand to acquire significant government funding in the event of a manufactured pandemic scenario."

(Taken from the Video Source)

_____________________

PCR testing detects genetic fragments. It is not a diagnostic tool. However it is the perfect tool for creating pseudo-epidemics. Learn more about pseudo-epidemics here:
https://blog.plan99.net/pseudo-epidemics-7603b2da839

VIDEO SOURCE: https://www.dossier.today/p/deborah-birx-proposes-weekly-testing